Pilot phase III immunotherapy study in early-stage breast cancer patients using oxidized mannan-MUC1 [ISRCTN71711835]

INTRODUCTION: Mucin 1 (MUC1) is a high molecular weight glycoprotein overexpressed on adenocarcinoma cells and is a target for immunotherapy protocols. To date, clinical trials against MUC1 have included advanced cancer patients. Herein, we report a trial using early stage breast cancer patients and...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Apostolopoulos, Vasso, Pietersz, Geoffrey A, Tsibanis, Anastasios, Tsikkinis, Annivas, Drakaki, Heleni, Loveland, Bruce E, Piddlesden, Sara J, Plebanski, Magdalena, Pouniotis, Dodie S, Alexis, Michael N, McKenzie, Ian F, Vassilaros, Stamatis
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2006
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC1557739/
https://ncbi.nlm.nih.gov/pubmed/16776849
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/bcr1505
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы